K+ channel modulators for the treatment of neurological disorders and autoimmune diseases.
Wulff
Heike
H
Department of Pharmacology, University of California, Davis, California 95616, USA. hwulff@ucdavis.edu
Zhorov
Boris S
BS
D000818:Animals; D001327:Autoimmune Diseases / Q000188:drug therapy* / Q000378:metabolism*; D006801:Humans; D007249:Inflammation / Q000188:drug therapy / Q000378:metabolism; D009422:Nervous System Diseases / Q000188:drug therapy* / Q000378:metabolism*; D026902:Potassium Channel Blockers / Q000627:therapeutic use*; D015221:Potassium Channels / Q000737:chemistry / Q000378:metabolism*
D026902:Potassium Channel Blockers; D015221:Potassium Channels